Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

In the latest market close, Adma Biologics (ADMA) reached $12.28, with a +0.82% movement compared to the previous day. This move lagged the S&P 500's daily gain of 1.08%. Meanwhile, the Dow gained ...

Adma Biologics is on the Move, Here's Why the Trend Could be Sustainable While "the trend is your friend" when it comes to short-term investing or trading, timing entries into the trend is a key ...

There are several stocks that passed through the screen and Adma Biologics (ADMA) is one of them. Here are the key reasons why this stock is a solid choice for "trend" investing. A solid price ...

ADMA Biologics will release figures for Q2 on August 8. Analysts predict earnings per share of $0.080. Go here to follow ADMA Biologics stock price in real-time ahead of earnings. On August 8 ...

Adma Biologics (ADMA) closed at $13.58 in the latest trading session, marking a -1.31% move from the prior day. This change was narrower than the S&P 500's daily loss of 2.32%. At the same time ...

Adma Biologics (ADMA) closed the most recent trading day at $13.05, moving -1.81% from the previous trading session. The stock fell short of the S&P 500, which registered a loss of 0.78% for the day.

ADMA Biologics (ADMA – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on the ...

There are several stocks that passed through the screen and (ADMA) is one of them. Here are the key reasons why this stock is a solid choice for "trend" investing. A solid price increase over a ...